The notices it replaced
- Reissues: PAR-24-287 Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
- 2 steps back: PAR-22-119 Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
- 3 steps back: PAR-19-257 Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
- 4 steps back: PAR-16-268 Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
Who won it before
42 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,429,973 in first-year total cost, median $85,045.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]42
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL5
- MASSACHUSETTS GENERAL HOSPITAL4
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO4
- JOHNS HOPKINS UNIVERSITY3
- YALE UNIVERSITY3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Novel Modulators of Limb Development and Chondrocyte Maturation1R03AR085214-01 · under PAR-22-119 | RENTHAL, NORA EDWARDS | BOSTON CHILDREN'S HOSPITAL, MA | $177,000 | AMS |
| 2025 | Characterizing Injury-Related Fear in Patients after Anterior Cruciate Ligament Reconstruction1R03AR085215-01 · under PAR-22-119 | BAEZ, SHELBY | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $165,527 | AMS |
| 2025 | Glucagon-like peptide-1 receptor agonists in lupus1R03AR085677-01 · under PAR-22-119 | JORGE, APRIL | MASSACHUSETTS GENERAL HOSPITAL, MA | $165,000 | AMS |
| 2025 | Applying Service Design Methods to Enhance Implementation and Adoption of a Digital Graded Exposure Treatment for Youth with Chronic Musculoskeletal Pain in Clinical Settings1R03AR084020-01A1 · under PAR-22-119 | HARRISON, LAUREN ELISABETH | STANFORD UNIVERSITY, CA | $154,000 | AMS |
| 2024 | The role of UBR5 in skeletal muscle atrophy and regrowth1R03AR083980-01 · under PAR-22-119 | HUGHES, DAVID C | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | $170,500 | AMS |
| 2024 | Systemic Treatments and Outcomes for Pediatric Atopic Dermatitis: Setting the Stage for Comparative Effectiveness Research1R03AR084585-01 · under PAR-22-119 | WAN, JOY | JOHNS HOPKINS UNIVERSITY, MD | $170,490 | AMS |
| 2024 | Examining endothelial cell and its plasticity in intramembranous bone regeneration1R03AR082927-01A1 · under PAR-22-119 | KO, FRANK | RUSH UNIVERSITY MEDICAL CENTER, IL | $158,000 | AMS |
| 2024 | Interrogation of T cell Bystander Activation in Scleroderma1R03AR083454-01 · under PAR-22-119 | ODELL, IAN D | YALE UNIVERSITY, CT | $147,400 | AMS |
| 2024 | Trained immunity as a link between Inflammatory Arthritis and development of Cardiovascular Disease1R03AR084000-01 · under PAR-22-119 | MACLAUCHLAN, SUSAN C. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $139,895 | AMS |
| 2024 | Endothelial Signaling in Exercise Metabolism1R03AR083493-01 · under PAR-22-119 | CRAIGE, SIOBHAN M | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $72,753 | AMS |
| 2023 | Therapeutic potential of systemic and localized zinc delivery for modulating fracture repair1R03AR082449-01 · under PAR-22-119 | HAST, MICHAEL WILLIAM | UNIVERSITY OF PENNSYLVANIA, PA | $162,500 | AMS |
| 2023 | Role of antiviral signaling in psoriatic pathogenesis1R03AR082350-01 · under PAR-22-119 | RAZANI, BAHRAM | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $161,500 | AMS |
| 2023 | Illuminating IL-31-producing cells in allergic skin disease1R03AR082948-01 · under PAR-22-119 | FASSETT, MARLYS S | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $161,500 | AMS |
| 2023 | Mechanisms of reticulophagy and ER stress mitigation in epidermis1R03AR082896-01 · under PAR-22-119 | SIMPSON, CORY L | UNIVERSITY OF WASHINGTON, WA | $88,250 | AMS |
| 2023 | Evaluating the relationship between immune checkpoint inhibitors and osteoarthritis1R03AR081997-01 · under PAR-19-257 | CAPPELLI, LAURA CHRISTINE | JOHNS HOPKINS UNIVERSITY, MD | $81,875 | AMS |
| 2023 | Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis1R03AR082036-01 · under PAR-19-257 | NAYAK, RENUKA RAJENDRA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $80,750 | AMS |
| 2022 | Causal Inference for Better Understanding Clinical Trials Results: Reconciling Discrepant Comparative Evidence from Two Major Cardiovascular Safety Trials of Urate-Lowering Therapy1R03AR081309-01 · under PAR-19-257 | TEDESCHI, SARA K. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2022 | Allele Specific Knockdown for LGMD-D11R03AR081395-01 · under PAR-19-257 | FINDLAY, ANDREW | WASHINGTON UNIVERSITY, MO | $78,729 | AMS |
| 2022 | Engineering recombinant lubricin to combat orthopedic infection1R03AR078961-01A1 · under PAR-19-257 | REESINK, HEIDI | CORNELL UNIVERSITY, NY | $78,500 | AMS |
| 2021 | Personalizing AAV Management by Leveraging Big Data: Targeting Complication Clusters1R03AR078938-01 · under PAR-19-257 | WALLACE, ZACHARY SCOTT | MASSACHUSETTS GENERAL HOSPITAL, MA | $105,843 | AMS |
| 2021 | Post-transcriptional Regulation of IL-21 in Human T Cells1R03AR078347-01 · under PAR-19-257 | RAO, DEEPAK ANGARA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2021 | Risk factors for anterior knee pain and the relation to future patellofemoral osteoarthritis1R03AR077698-01A1 · under PAR-19-257 | STEFANIK, JOSHUA JON | NORTHEASTERN UNIVERSITY, MA | $88,969 | AMS |
| 2021 | Atopic dermatitis in childhood and risk of early cardiovascular disease1R03AR078962-01 · under PAR-19-257 | ABUABARA, KATRINA ELAINE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $80,750 | AMS |
| 2021 | Enhancing Patient Education through a 'Journey Guide' For Adult Traumatic Brachia! Plexus Injury1R03AR077109-01A1 · under PAR-19-257 | DY, CHRISTOPHER JOHN | WASHINGTON UNIVERSITY, MO | $78,750 | AMS |
| 2021 | The Role of Biofilm Formation in Antibiotic Tolerant Periprosthetic Joint Infection1R03AR077602-01A1 · under PAR-19-257 | URISH, KENNETH L | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $78,250 | AMS |
| 2020 | Genetic and Functional Traits of Cultivated Nasal Bacteria in Relapsing Granulomatosis with Polyangiitis1R03AR077697-01 · under PAR-19-257 | RHEE, RENNIE | UNIVERSITY OF PENNSYLVANIA, PA | $102,186 | AMS |
| 2020 | Electron microscopy analysis of novel knob-pocket mechanism critical for intermediate filament assembly1R03AR076484-01 · under PAR-16-268 | BUNICK, CHRISTOPHER GERARD | YALE UNIVERSITY, CT | $83,750 | AMS |
| 2020 | Risk of Fractures and Joint Replacement Surgeries with TNF-inhibitor Use in Ankylosing Spondylitis1R03AR076495-01 · under PAR-16-268 | DUBREUIL, MAUREEN | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $82,500 | AMS |
| 2020 | Bone Turnover Responses to Sleep Restriction and Subsequent Sleep Recovery1R03AR074509-01A1 · under PAR-16-268 | SWANSON, CHRISTINE M | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | AMS |
| 2020 | Role of the Alternative Complement Cascade in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH)1R03AR075866-01A1 · under PAR-19-257 | KORMAN, BENJAMIN DOUGLAS | UNIVERSITY OF ROCHESTER, NY | $77,000 | AMS |
| 2019 | Respiratory Diseases, Genetics, and Rheumatoid Arthritis Risk1R03AR075886-01 · under PAR-16-268 | SPARKS, JEFFREY ANDREW | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2019 | The role of mitochondrial Damage Associated Molecular Patterns (mDAMPs) in posttraumatic osteoarthritis.1R03AR075929-01 · under PAR-16-268 | DELCO, MICHELLE LEE | CORNELL UNIVERSITY, NY | $78,500 | AMS |
| 2019 | CRISPR Screen to Identify Novel Secreted Epidermal Regulators1R03AR075844-01 · under PAR-16-268 | SUN, BRYAN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $66,330 | AMS |
| 2018 | The role of 1,25 dihydroxyvitamin D in osteocyte perilacunar and canalicular remodeling1R03AR073899-01 · under PAR-16-268 | LIU, EVA S. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2018 | Dissecting the Temporal Role of Dermal Wnt/Beta-Catenin Signaling in Hair Follicle Induction During Development and Regenerative Wound Healing1R03AR072807-01 · under PAR-16-268 | MYUNG, PEGGY S | YALE UNIVERSITY, CT | $83,750 | AMS |
| 2018 | Reducing cartilage destruction in osteoarthritis with the small molecule SIK inhibitor YKL-05-0991R03AR072903-01 · under PAR-16-268 | WEIN, MARC NATHAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $83,596 | AMS |
| 2018 | Movement screening and modification in individuals with femoroacetabular impingement syndrome1R03AR072808-01 · under PAR-16-268 | LEWIS, CARA L | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $82,416 | AMS |
| 2018 | Angiogenic Potential in Children with Glucocorticoid-Induced Osteoporosis1R03AR073939-01 · under PAR-16-268 | CRANE, JANET | JOHNS HOPKINS UNIVERSITY, MD | $81,875 | AMS |
| 2018 | Cytosolic DNA sensors in cutaneous wound healing and host defense1R03AR073940-01 · under PAR-16-268 | SCUMPIA, PHILIP | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $78,000 | AMS |
| 2017 | Skeletal effects of the small molecule SIK inhibitor YKL-05-0991R03AR072150-01 · under PAR-16-268 | WEIN, MARC NATHAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $85,339 | AMS |
| 2017 | Human Gut Microbiome as Modulator of Drug Response in Inflammatory Arthritis1R03AR072182-01 · under PAR-16-268 | SCHER, JOSE U. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $84,750 | AMS |
| 2017 | Identification of BATF2 as a Regulator of Interferon-Enhanced Inflammatory Responses in Lupus Skin1R03AR072107-01 · under PAR-16-268 | KAHLENBERG, JOANNE MICHELLE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $77,500 | AMS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.